Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy
Regulation of Choroidal Neovascularization in Sorsby's Fundus Dystrophy
批准号:
9900004
负责人:
BELA ANAND-APTE
金额:
$39.63万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-04-01 至 2021-05-31
关键词:
Age related macular degenerationAngiogenesis InhibitionAngiogenesis InhibitorsAngiogenic FactorBilateralBindingBlindnessC-terminalCD44 geneCellsChoroidChoroidal NeovascularizationClinicalCodeComparative StudyDataDegenerative DisorderDevelopmentDiseaseEndothelial CellsExonsExposure toExtracellular MatrixExudative age-related macular degenerationFGF2 geneFibroblast Growth Factor ReceptorsFunctional disorderGenesGrowth FactorHyaluronanIn VitroInheritedKDR geneKnock-in MouseKnowledgeLaboratoriesLasersLeadMMP9 geneMatrix MetalloproteinasesMediatingMitogen-Activated Protein KinasesModelingMolecularMusMutant Strains MiceMutationPathologicPathway interactionsPatientsPeptidesPhenotypePhosphorylationPlayProtein RegionProteinsRare DiseasesRegulationReportingRetinaRoleSTAT3 geneSignal TransductionSorsby&aposs fundus dystrophyTIMP3 geneTestingTransgenic MiceTumor Cell MigrationVariantVascular Endothelial Growth FactorsVisionangiogenesisbaseexperimental studygenetic associationmaculamutantneovascularizationnew therapeutic targetnovelnovel therapeutic intervention
中文摘要
项目摘要
Sorsby眼底营养不良(SFD)是一种显性遗传性黄斑变性疾病,
其特征在于作为脉络膜新生血管形成(CNV)的结果的双侧中心视力丧失。
TIMP-3基因中涉及外显子5或内含子4-外显子5边界的特异性突变已被证明,
是causative。今年早些时候,AMD联盟在TIMP 3基因中发现了罕见的编码变体,
分析了16,144名患者和17,832名对照。此外,他们还发现了第一个遗传关联信号,
特异于MMP 9附近的湿性AMD。AMD和SFD之间的临床和组织病理学相似性
并且在AMD中基质金属蛋白酶途径中的变体的鉴定表明,类似的
下游效应物可能在这两种情况下起作用。更好地理解病理生理学
在SFD中促进CNV的机制将提供可能在以下方面有用的信息:
AMD.在使用TIMP-3缺陷小鼠、S156 CTIMP-3转基因小鼠和体外培养的比较研究中,
培养实验中,我们已经确定TIMP-3通过阻断TIMP-3与血管内皮细胞的结合而部分抑制血管生成。
VEGR-2的表达。S156 C TIMP-3突变蛋白通过VEGF和bFGF诱导血管生成。我们有
还表明,功能性TIMP-3的缺乏导致透明质酸的积累,
脉络膜脉管系统基于这些结果,我们假设TIMP 3是控制和定位
RPE/脉络膜中的基质降解,以及TIMP 3功能的丧失导致RPE/脉络膜中的异常。
生长因子/血管生成因子,增加HA信号传导和新血管形成。
英文摘要
PROJECT SUMMARY
Sorsby fundus dystrophy (SFD) is a dominantly inherited, degenerative disease of the macula that is
characterized by bilateral loss of central vision as a consequence of choroidal neovascularization (CNV).
Specific mutations in the TIMP-3 gene involving exon 5 or the intron4-exon5 boundary have been shown to
be causative. Early this year, the AMD consortium identified rare coding variants in the TIMP3 gene when
analyzing 16,144 patients and 17,832 controls. In addition, they identified the first genetic association signal
specific to wet AMD near MMP9. The clinical and histopathological similarities between AMD and SFD
and the identification of variants in the matrix metalloproteinase pathway in AMD suggest that similar
downstream effectors might be in play in both conditions. A better understanding of the pathophysiological
mechanisms contributing to the CNV in SFD will provide information that could be potentially useful in
AMD. In comparative studies using TIMP-3 deficient mice, S156CTIMP-3 transgenic mice and in vitro
culture experiments we have determined that TIMP-3 partially inhibits angiogenesis by blocking the binding
of VEGF to VEGR-2. S156C TIMP-3 mutant protein induces angiogenesis via VEGF and bFGF. We have
also shown that the absence of functional TIMP-3 results in an accumulation of hyaluronan that regulates
choroidal vasculature. Based on these results, we hypothesize that TIMP3 is required to control and localize
matrix degradation in the RPE/choroid, and loss of TIMP3 function in this regards leads to an abnormality in
growth factor/angiogenesis factor, increased HA signaling and neovascularization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.
-
批准号:10408757
-
项目类别:
-
资助金额:$62.17万
-
财政年份:2017
-
负责人:BELA ANAND-APTE
-
依托单位:
FGF and hyaluronan-mediated alterations in epithelial-mesenchymal transition and metabolism of RPE cells in Sorsby Fundus Dystrophy.
-
批准号:10636830
-
项目类别:
-
资助金额:$61.01万
-
财政年份:2017
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
-
批准号:9769753
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
NEI CENTER CORE GRANT FOR VISION RESEARCH
-
批准号:9336307
-
项目类别:
-
资助金额:$63.4万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
NEI Center Core Grant for Vision Research
-
批准号:10273076
-
项目类别:
-
资助金额:$64.4万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
CORE A - Administrative Core
-
批准号:10273077
-
项目类别:
-
资助金额:$2.26万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
NEI Center Core Grant for Vision Research
-
批准号:10670892
-
项目类别:
-
资助金额:$64.4万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
-
批准号:9334214
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of Retinoic Acid in the Regulation of the Blood-Retinal Barrier.
-
批准号:10011815
-
项目类别:
-
资助金额:$41.3万
-
财政年份:2016
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:10407662
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:10595051
-
项目类别:
-
资助金额:$3.62万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:9027846
-
项目类别:
-
资助金额:$17.4万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:9262929
-
项目类别:
-
资助金额:$12.6万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Cole Eye Institute Vision Science Training Program
-
批准号:8855069
-
项目类别:
-
资助金额:$16.87万
-
财政年份:2015
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of betacellulin in diabetic macular edema
-
批准号:8231532
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of betacellulin in diabetic macular edema
-
批准号:8107705
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2011
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of betacellulin in diabetic macular edema
-
批准号:8449210
-
项目类别:
-
资助金额:$37.29万
-
财政年份:2011
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of betacellulin in diabetic macular edema
-
批准号:8657047
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2011
-
负责人:BELA ANAND-APTE
-
依托单位:
CAN CD 133 CELLS PREVENT HYPOXIA DRIVEN RETINAL NEOVASCULARISATION IN A RODENT MO
-
批准号:7405687
-
项目类别:
-
资助金额:$31.06万
-
财政年份:2007
-
负责人:BELA ANAND-APTE
-
依托单位:
Role of TIMP-3 in Ocular Neovascularization
-
批准号:6910072
-
项目类别:
-
资助金额:$35.6万
-
财政年份:2005
-
负责人:BELA ANAND-APTE
-
依托单位:
海外基金